FluGen snaps up $12 mln Series A
Madison, Wisconsin-based FluGen Inc, which is currently developing a universal flu vaccine, has closed $12 million in Series A funding. The investors included Knox LLC, Venture Investors LLC, the Wisconsin Alumni Research Foundation and the State of Wisconsin Investment Board. In conjunction with the funding, FluGen has added Dr. Dan Stinchcomb and C. Boyd Clarke to its board of directors.
25 August 2015•5 mins read
